02/22/21 4:08 PMNYSE : QGEN, QIA managementQIAGEN Expands Supervisory Board With Appointment of a New MemberQIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today the appointment of Thomas Ebeling, a leading international executive with extensive experience in the healthcare, media and consumer goods industries, as a member of the Supervisory Board with immediate effect.Mr. Ebeling joinsRHEA-AIneutral
02/09/21 4:05 PMNYSE : QGEN, QIA QIAGEN Beats Outlook for Fourth Quarter and Full-Year 2020, Reaffirms Expectations for Further Growth in 2021QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced strong results of operations for the fourth quarter and full-year 2020, exceeding the goals for net sales and adjusted earnings per share.Net sales in the fourth quarter of 2020 rose 38% (+36% at constant exchange rates, CER) toRHEA-AIneutral
01/28/21 4:05 PMNYSE : QGEN covid-19QIAGEN Adds dPCR Platform QIAcuity to Growing Portfolio of COVID-19 Testing Solutions for Wastewater and Mutation TestingQIAGEN today announced the addition of kits for wastewater testing to its growing portfolio of COVID-19 products. The use of dPCR in the worldwide surveillance of COVID-19 is an additional step towards making digital PCR (dPCR) an affordable and standard instrument for a host of applications inRHEA-AIneutral
01/26/21 7:10 AMNYSE : QGEN conferencesQIAGEN N.V. to Report Fourth Quarter and Full-Year 2020 ResultsQIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced today that it plans to release its report on results for the fourth quarter and full-year 2020 on Tuesday, February 9,at approximately 22:05 Central European Time (CET) / 16:05 Eastern Standard Time (EST).A conference call isRHEA-AIneutral
01/20/21 4:08 PMNYSE : QGEN, QIA QIAGEN Plans to Resubmit EUA Submission in the U.S. for QIAreach SARS-CoV-2 Antigen Test in the First Quarter of 2021QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it plans to resubmit in the first quarter of 2021 its QIAreach SARS-CoV-2 Antigen Test to the U.S. Food and Drug Administration for Emergency Use Authorization to detect SARS-CoV-2 antigens in people with active infectionsRHEA-AIneutral
01/20/21 4:05 PMNYSE : QGEN, QIA QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the CoronavirusQIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its polymerase chain reaction (PCR) tests remain accurate and effective in detecting SARS-CoV-2 infections – and will continue to closely monitor their performance as global concerns mount regarding the detection of new viralRHEA-AIneutral
01/08/21 7:00 AMNYSE : QGEN managementQIAGEN Announces Appointment of New Supervisory Board MemberQIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that Dr. Toralf Haag has been appointed a member of the Supervisory Board with immediate effect. He will also become a member of the Audit Committee.Dr. Haag was chosen as part of an expansion process launched by the SupervisoryRHEA-AIneutral
12/17/20 4:05 PMNYSE : QGEN, QIA QIAGEN Underlines and Innovates Its Commitment to Sustainability With a EUR 400mn Sustainability-linked Credit FacilityQIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard QIA) announced today that it has successfully concluded a syndicated revolving credit facility for EUR 400mn with an interest rate linked to the company’s environmental, social and governance (ESG) performance.The agreement makes QIAGEN the firstRHEA-AIvery positive
12/11/20 6:02 PMNYSE : QGEN QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible Bonds and Price to Non-US Holders to Sell Outstanding Convertible Notes Due 2021QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) ("QIAGEN" or the "Company") announces the successful pricing of the following series of transactions: - The issue of new senior, unsecured net share settled convertible bonds, which may be converted, in part, into ordinary shares of the Company ("Shares"), due 2027 (the "New Bonds") outside the United States for $500 million aggregate principal amount; and - The repurchase of $172.8 million aggregatRHEA-AIneutral
12/08/20 1:45 AMNYSE : QGEN QIAGEN Increases Outlook for 2020 and 2021QIAGEN increases outlook for 2020 and 2021RHEA-AIvery positive
